Evidence map›Paper›PMID 27068518›Full record

ArticleVirology journal2016

Atlantic salmon (Salmo salar L.) post-smolts challenged two or nine weeks after seawater-transfer show differences in their susceptibility to salmonid alphavirus subtype 3 (SAV3).

J Jarungsriapisit, L J Moore, G L Taranger, T O Nilsen, H C Morton, I U Fiksdal, S Stefansson, P G Fjelldal, Ø Evensen, S Patel

Open access · goldAbstract read
In one paragraph

Article in Virology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Plasmid-DNA EncodedPharmaceutics · 2026
    Article
  2. Article
  3. Article
  4. Red Sea Bream Iridovirus (RSIV) Kinetics in Rock Bream (Animals : an open access journal from MDPI · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

J JarungsriapisitInstitute of Marine Research, Nordnesgaten 50, 5005, Bergen, Norway.
L J MooreInstitute of Marine Research, Nordnesgaten 50, 5005, Bergen, Norway.
G L TarangerInstitute of Marine Research, Nordnesgaten 50, 5005, Bergen, Norway.
T O NilsenUni Research Environment, Uni Research, Thormøhlensgt., 49 B, 5006, Bergen, Norway.
H C MortonInstitute of Marine Research, Nordnesgaten 50, 5005, Bergen, Norway.
I U FiksdalInstitute of Marine Research, Nordnesgaten 50, 5005, Bergen, Norway.
S StefanssonDepartment of Biology, University of Bergen, P.O. Box 7803, N-5020, Bergen, Norway.
P G FjelldalInstitute of Marine Research, Matre Research Station, Matredal, Norway.
Ø EvensenNorwegian University of Life Sciences, Faculty of Veterinary Medicine and Biosciences, P.O. Box 8146 Dep, N-0033, Oslo, Norway.
S PatelInstitute of Marine Research, Nordnesgaten 50, 5005, Bergen, Norway. sonal.patel@imr.no.
Norwegian Institute of Marine Research · NONorwegian University of Life Sciences · NOUni Research (Norway) · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPancreas disease (PD), caused by salmonid alphavirus (SAV), is an important disease affecting salmonid aquaculture. It has been speculated that Atlantic salmon post-smolts are more prone to infections in the first few weeks following seawater- transfer. After this period of seawater acclimatization, the post-smolts are more robust and better able to resist infection by pathogens. Here we describe how we established a bath immersion (BI) model for SAV subtype 3 (SAV3) in seawater. We also report how this challenge model was used to study the susceptibility of post-smolts to SAV3 infection in two groups of post-smolts two weeks or nine weeks after seawater - transfer.

methodsPost-smolts, two weeks (Phase-A) or nine weeks (Phase-B) after seawater- transfer, were infected with SAV3 by BI or intramuscular injection (IM) to evaluate their susceptibility to infection. A RT-qPCR assay targeting the non-structural protein (nsP1) gene was performed to detect SAV3-RNA in blood, heart tissue and electropositive-filtered tank-water. Histopathological changes were examined by light microscope, and the presence of SAV3 antigen in pancreas tissue was confirmed using immuno-histochemistry.

resultsVirus shedding from the Phase-B fish injected with SAV3 (IM Phase-B) was markedly lower than that from IM Phase-A fish. A lower percentage of viraemia in Phase-B fish compared with Phase-A fish was also observed. Viral RNA in hearts from IM Phase-A fish was higher than in IM Phase-B fish at all sampling points (p < 0.05) and a similar trend was also seen in the BI groups. Necrosis of exocrine pancreatic cells was observed in all infected groups. Extensive histopathological changes were found in Phase-A fish whereas milder PD-related histopathological lesions were seen in Phase-B fish. The presence of SAV3 in pancreas tissue from all infected groups was also confirmed by immuno-histochemical staining.

conclusionOur results suggest that post-smolts are more susceptible to SAV3 infection two weeks after seawater-transfer than nine weeks after transfer. In addition, the BI challenge model described here offers an alternative SAV3 infection model when better control of the time-of-infection is essential for studying basic immunological mechanisms and disease progression.

Indexed as

Disease SusceptibilityAlphavirus InfectionsAnimalsAquacultureBloodFish DiseasesHeartHistocytochemistryInjections, IntramuscularMicroscopyPancreasReal-Time Polymerase Chain ReactionRNA, ViralSalmo salarSeawaterRNA, ViralATPase activityBath challengeBath immersionCondition factorPancreas diseasePlasma cortisolSalmon pancreas disease virusSPDVViral shedding

Identifiers

PMID27068518
PMCPMC4827186
OpenAlexW2326020232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.